Niftypharma
SunPharma - Bull Flag - Long above 506NSE:SUNPHARMA is continuously getting hammered.
Long only above when the closing is above 506.
UPL - Bounce from lower trendline support?NSE:UPL may bounce from lower trendline support.
Track this.
Torrent Pharma - Big Bull Flag Consolidation - long ideaNSE:TORNTPHARM is currently at the demand zone.
One may look for going long here.
DR REDDY , 1 Day Analysis , Inside Bar Overall Strong Uptrend Move .
Previous 6 Days Price Stucked In A Range Formed Inside Bar 5 Candle Close In It .
ADX Above 25
+DI Above -DI
Buy Above :- 4080 (Aggressive) , 4128 (Conventional )
Sl :- 3950
Target :- 4310-4390
Trail Your Sl And Try to Ride the Big Rally .
Happy Trading .
Long Term Picture of Biocon - A really BullHey everyone,
Biocon is still a good buy 350-365 range for Long term Investment. Target should be 520 in the year 2020. Stock Momentum is good in upside and can be considered to add in any Portfolio.
ABBOTT INDIA - taking a pause nowNSE:ABBOTINDIA is facing a huge over head supply now.
Longs are doing profit booking.
Nifty Pharma - RSI Negative Divergence - Longs HedgeNSE:CNXPHARMA is displaying negative divergence on a daily timeframe.
Short term/swing traders may start to hedge their long positions, with call short.
Nifty Pharma - Bull Territory - BTFD - Above 9400 levelsNSE:CNXPHARMA has come into the bull territory, one may use the opportunity to buy on dips whenever it happens.
Cipla may pause its uptrend in this supply zone - Longs HedgeNSE:CIPLA can possibly pause its uptrend in this supply zone.
One hedge their long portfolios here.
NIFTY PHARMA | Trending ChannelNSE:CNXPHARMA is clearly moving in a side trend after a very huge rally of almost 1800 points, and it taking support on a major demand area and likely to go long.
Thanks for reading, hope you have a great day!
Nifty Pharma's Outperformance On PauseIn November the Nifty Pharma / Nifty 100 ratio met our downside objective as momentum diverged positively, sparking a massive 6-month period of outperformance from the Pharma sector. We've ridden this trend since it started, but prices are now back at the ratios 2014 lows and beginning to fail. What acted as support is now resistance...and following the massive run prices have had, this is a very logical level for prices to pull back and digest their recent gains. As long as prices are below their recent highs, then we'd expect the Pharma sector to underperform in the near-term. Long-term the trend in this ratio is clearly higher, but for now, we want to be taking profits as money rotates into other areas of the market that haven't run as much...like Nifty Financial Services. You can view our other ideas discussing this topic linked below.
Nifty Pharma Meets Near-Term ResistanceAfter a 55% rally off its March lows, the Nifty Pharma Index has confirmed a failed breakout by closing back below resistance at its early 2019 highs of 9,500. As long as prices are below that level then we'd expect some near-term weakness in this hot sector. There's a large level of support down below near 8,350, so as long as prices are above that level then any pullback would be viewed as constructive digestion of the recent gainst. We're seeing a rotation out of areas like Pharma that have led the recent rally and into laggards like Financial Services which will push the major indices higher in the near-term. Overall, the Pharma sector remains one of the strongest areas of the market, but our expectation is for some profit-taking in the coming days and weeks.
CIPLA LOOKS BEARISH TO MEPharma Giant Cipla is forming a classical Lower Top Lower Bottom Formation
Looks weak to me
Do ur own analysis before taking trades :)
DIVIS LAB - SHORT TERM SWING DIVIS LAB
SHORT 1850-1855
SL: 1870
TARGETS: 1824/1780/1762 ===>> TIME SPAN 1 WEEK
#TORNTPHARM Cup and Handle Breakout @anish_sharmaaa#TORNTPHARM Cup and Handle Breakout @anish_sharmaaa
View negated below 1595...
A potential long on Aurobindo Pharma!A long trade can be initiated around 675 levels, if Aurobindo Pharma sustains above it's resistance zone above 650, with targets close to 800 and a stop loss around 615. The Risk to reward is high, with the trade having high probabilities of success, if 675 is tested and our entry price is hit.
AjantaPharm Near Left Shoulder Support - Potential Buy FOR EDUCATION / PAPER TRADING PURPOSE.
Buy as per Left Shoulder support and Fibonacci confluence. With STOP below the Fib 0.
CNX Pharma- Bulls are getting Ready?Pharma Index has been in downtrend since Dec 2017, but now it has shown some strength at 8800-8300 levels. On monthly chart index has formed bullish pattern which gives us confirmation for upside.Trade with the levels.
